A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MDRO / multidrug-resistant organisms

[Related PubMed/MEDLINE]
Total Number of Papers: 324
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MDRO  (>> Co-occurring Abbreviation)
Long Form:   multidrug-resistant organisms
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2023 A Curious Case of Chryseobacterium indologenes Culture in a Young Adult Kidney Transplant Patient. C. indologenes
2023 Comparative analysis of pathogen distribution in patients with fracture-related infection and periprosthetic joint infection: a retrospective study. FRI, PJI
2023 Decrease in Mortality from Sepsis: Impact of the Multidisciplinary Program for the Hematologic Patient at Very High Risk. HSCT
2023 Effect of daily chlorhexidine bathing on reducing infections caused by multidrug-resistant organisms in intensive care unit patients: A semiexperimental study with parallel controls. CRAB, CRE, CRPA, DID
2023 Fever of Unknown Origin and Multidrug Resistant Organism Colonization in AML Patients. AML, FUO
2023 Impact of multidrug resistance on the management of bacterial infections in cirrhosis. ---
2023 Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremia. AMS, CDI, LOS, RDTs
2023 Implementation of A Year-Long Antimicrobial Stewardship Program in A 227-Bed Community Hospital in Southern Italy. AMS, HAIs
2023 Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All. LMICs
10  2023 Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022. NDM
11  2023 Multiple-Site Decontamination in mechanically ventilated ICU patients: a real-life study. BSI, MSD, SC, VAP
12  2023 The impact of bedside wipes in multi-patient rooms: a prospective, crossover trial evaluating infections and survival. HAI
13  2022 A Narrative Review on the Approach to Antimicrobial Use in Ventilated Patients with Multidrug Resistant Organisms in Respiratory Samples-To Treat or Not to Treat? That Is the Question. ---
14  2022 A qualitative study examining the impact of multidrug-resistant organism (MDRO) carriage on the daily lives of carriers and parents of carriers with experiences of hospital precautionary measures. HCPs
15  2022 Active Surveillance Cultures and Procalcitonin in Combination With Clinical Data to Guide Empirical Antimicrobial Therapy in Hospitalized Medical Patients With Sepsis. ASC, q-SOFA, rectal or nasal, SIRS
16  2022 Analyzing the Cost of Hospital Contact Isolation Practices: Implications for Nursing Administrator Practice, Research, and Policy. CP, MRSA, PPE
17  2022 Association of Exposure to High-risk Antibiotics in Acute Care Hospitals With Multidrug-Resistant Organism Burden in Nursing Homes. AWARE, NHs, OR
18  2022 Association of Multidrug Resistance Bacteria and Clinical Outcomes of Adult Patients with Sepsis in the Intensive Care Unit. AC, HAI, LOS, MVA
19  2022 Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients. ICU, OR
20  2022 Clinical and economic burden of bacteremia due to multidrug-resistant organisms in Korea: a prospective case control study. CRE, MRAB, MRPA, MRSA, VRE
21  2022 Clinical characteristics and risk factors for multidrug-resistant bacterial isolation in patients with international travel history. ESBL-EC
22  2022 Clinical Characteristics of Acute Pancreatitis Patients with Multidrug-Resistant Bacterial Infection. AP, CRAB, CRKP, HTG
23  2022 Clinical Implications of Multi-Drug Resistant Organisms' Gastrointestinal Colonization in an Internal Medicine Ward: The Pandora's Box. CI, ICUs, ORs
24  2022 Clinical Outcomes Associated with Co-infection of Carbapenem-Resistant Enterobacterales and other Multidrug-Resistant Organisms. aOR, CI, CRE, CRPA, MDRA, MRSA
25  2022 Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set. ICU-AI
26  2022 Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinoma. CCA, OS
27  2022 Combination of isothiocyanates and antibiotics increases susceptibility against Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens. ITC, MIC, UTI
28  2022 Comparing the efficacy of different methods of faecal microbiota transplantation via oral capsule, oesophagogastroduodenoscopy, colonoscopy, or gastric tube. FMT
29  2022 Current state of antimicrobial stewardship and organ transplantation in Saudi Arabia. AMR, ASP
30  2022 Early Versus Delayed Enteral Feeding in Predicted Severe Acute Gallstone Pancreatitis: A Retrospective Study. EN, SAGP
31  2022 Effect of a real-time automatic nosocomial infection surveillance system on hospital-acquired infection prevention and control. BSI, HAI, HAIs, NPV, PPV, RT-NISS, RT-NISSs, Se, Sp, SSI, UTI
32  2022 Enhanced disinfection with hybrid hydrogen peroxide fogging in a critical care setting. ACC, ATP, EVS, MRSA, UV
33  2022 Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening. AMS, LTR, VRE
34  2022 European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad. AMR, ESBL, MRSA
35  2022 Frequency of microbial isolates and pattern of antimicrobial resistance in patients with hematological malignancies: a cross-sectional study from Palestine. DTR, E. coli, GNB, GPB
36  2022 Genomic transmission analysis of multidrug-resistant Gram-negative bacteria within a newborn unit of a Kenyan tertiary hospital: A four-month prospective colonization study. CRO, KNH, WGS
37  2022 Gram-negative multidrug-resistant organisms were dominant in neurorehabilitation ward patients in a general hospital in southwest China. A. baumannii, K. pneumonia, P. aeruginosa
38  2022 High prevalence of multidrug-resistant Gram-negative bacteria carriage in children screened prospectively for multidrug resistant organisms at admission to a paediatric hospital, Hamburg, Germany, September 2018 to May 2019. CI, MRGN, MRSA, OR, VRE
39  2022 Hyaluronic Acid and Chondroitin Sulphate Treatment for Recurrent Severe Urinary Tract Infections due to Multidrug-Resistant Gram-Negative Bacilli in a Patient With Multiple Sclerosis: Case Report and Literature Review. CS, HA, UTIs
40  2022 Hygiene management for long-term ventilated persons in the home health care setting: a scoping review. HMV, MRSA
41  2022 Impact of early antibiotic exposure on the risk of colonization with potential pathogens in very preterm infants: a retrospective cohort analysis. NICUs
42  2022 Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2. BMI, COVID-19, ICU, IMV, LOS, MRSA, SOFA, VAP
43  2022 Infection with Two Multi-Drug-Resistant Organisms in Solid Organ Transplant Patients Is Associated with Increased Mortality and Prolonged Hospitalization. CI, OR
44  2022 Investigation of a Candida auris outbreak in a Skilled Nursing Facility - Virginia, United States, October 2020-June 2021. vSNF
45  2022 Knowledge, Attitudes, and Practices of NICU Doctors and Nurses Toward Prevention and Control of Nosocomial Infection With Multidrug Resistant Organism. KAP, NICUs
46  2022 Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections. BSIs, CLABSI, NHSN, RR
47  2022 Longitudinal Evaluation of Gut Bacteriomes and Viromes after Fecal Microbiota Transplantation for Eradication of Carbapenem-Resistant Enterobacteriaceae. CRE, FMT
48  2022 Metal nanoparticles and nanoparticle composites are effective against Haemophilus influenzae, Streptococcus pneumoniae, and multidrug-resistant bacteria. CRAB, CRKP, MICs, MRSA, Se-NP
49  2022 Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus. VRE
50  2022 Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis. ESBL-Ec, ESBL-Kp
51  2022 Multidrug-resistant organisms in paediatric palliative care patients - Prevalence, risk factors and the impact of a liberal hygiene concept. PPC
52  2022 Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis. aOR, CI, NVOs, OT
53  2022 Patterns of microbial resistance in bloodstream infections of hemodialysis patients: a cross-sectional study from Palestine. BSIs, CoNS, CVCs, ESBL, HD
54  2022 Prevalence of Multi Drug Resistant Organism in ICU Burns Patients at Tertiary Care Hospital. LOS, TBSA
55  2022 Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India. AML, CRE, FN, LMIC
56  2022 Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms. GREAT, IDST
57  2022 Risk Factors for Antibiotic Resistant Urinary Pathogens in Patients Discharged From the Emergency Department. ED, EMPs, OR, UTIs
58  2022 Risk factors for colonization by carbapenemase-producing bacteria in Spanish long-term care facilities: a multicentre point-prevalence study. CI, CPB, LTCF, MDRAB, MRSA, OR, VRE
59  2022 Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults. AKI, Ccr, CPB, ICU, VAP
60  2022 Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study. CI, COVID-19, OR, SSC, SSC-CIP, UDCA
61  2022 Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea. MRAB, MRAB-P, MRPA-P
62  2022 Spread of Multidrug-Resistant Microorganisms. ---
63  2022 Study on the Detection and Infection Distribution of Multidrug-Resistant Organisms in Different Specimens. ---
64  2022 Synergistic effects of length of stay and prior MDRO carriage on the colonization and co-colonization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and carbapenemase-producing Enterobacterales across healthcare settings. ACH, CI, CPE, ILTCFs, MRSA, OR, VRE
65  2022 The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. CRAB, PPE
66  2022 The effect of a full-time infection control nursing service in the prevention of multidrug-resistant organism in the orthopedic ward. ---
67  2022 The Impact of Antimicrobial Stewardship in Children in Low- and Middle-income Countries: A Systematic Review. AMR, AMS, LMIC
68  2022 What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres. ASPs
69  2022 [Pathogen Distribution,Imaging Characteristics,and Establishment and Verification of Risk Prediction Model of Pulmonary Infection with Multi-drug Resistant Organism in Patients with Severe Craniocerebral Injury]. ---
70  2021 Acquisition and carriage of multidrug-resistant organisms in dogs and cats presented to small animal practices and clinics in Switzerland. CI, CP, MR, OR
71  2021 Antimicrobial-Resistant Bacteria and Prescription of Antibiotics at a Tertiary Care Hospital in Riyadh, Saudi Arabia. A. baumannii, CRE, E. coli, K. pneumoniae, P. aeruginosa, P. mirabilis, S. aureus
72  2021 Bloodstream infections in older population: epidemiology, outcome, and impact of multidrug resistance. BSIs, CoNS, MRSA
73  2021 Clinical outcome of Maggot Debridement Therapy followed by Negative Pressure Wound Therapy for chronic hand wound with Multi-Drug Resistant Organism infection: Two cases and review of the literature. MDT
74  2021 Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study. BSIs, COVID-19, ICU, RT-PCR
75  2021 Clinical significance of MDRO screening and infection risk factor analysis in the ICU. ICU
76  2021 Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma. HCC
77  2021 Colonization with Multidrug-resistant Organisms in Patients with Ventricular Assist Devices. VAD
78  2021 Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates. CRGN, LT, MDRGN, MRSA, VRE
79  2021 Contamination of Retail Meat Samples with Multidrug-Resistant Organisms in Relation to Organic and Conventional Production and Processing: A Cross-Sectional Analysis of Data from the United States National Antimicrobial Resistance Monitoring System, 2012-2017. aPR
80  2021 Diagnostic stewardship based on patient profiles: differential approaches in acute versus chronic infectious syndromes. ---
81  2021 Doctors' Perceptions, Attitudes and Practices towards the Management of Multidrug-Resistant Organism Infections after the Implementation of an Antimicrobial Stewardship Programme during the COVID-19 Pandemic. ASP
82  2021 Effects of healthcare failure mode and effect analysis on the prevention of multi-drug resistant organisms infections in oral and maxillofacial surgery. ESCA, FMEA, RPN
83  2021 Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities. CP
84  2021 Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract - a systematic review. FMT
85  2021 Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation. FMT, HCT, NRM
86  2021 High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission. MDROs
87  2021 Impact of multimodal strategies to reduce multidrug-resistant organisms in surgical intensive care units: Knowledge, practices and transmission: A quasi-experimental study. HCP, SICUs
88  2021 Influence of patient isolation due to colonization with multidrug-resistant organisms on functional recovery after spinal cord injury. SCI
89  2021 Interfacility transfer communication of multidrug-resistant organism colonization or infection status: Practices and barriers in the acute-care setting. IFTC, SHEA
90  2021 Interprofessional perceptions of emotional, social, and ethical effects of multidrug-resistant organisms: A qualitative study. ---
91  2021 Investigation of possible transmission of a susceptible microorganism through a contaminated duodenoscope; a case report. AFLP, DAIs, ERCP, MLST
92  2021 Multi-Drug Resistant Organisms Infection Impact on Patients Length of Stay in Respiratory Care Ward. CRPA, LOS, RCW
93  2021 Multidrug-resistant organism (MDRO) contamination of privacy curtains in nursing homes. ---
94  2021 Observational study over 8-year period evaluating microbiological characteristics and risk factor for isolation of multidrug-resistant organisms (MDRO) in patients with healthcare-associated infections (HAIs) hospitalized in a urology ward. ESBL, HAIs, PCNU, UTI
95  2021 Periprosthetic Joint Infection Prophylaxis in the Elderly after Hip Hemiarthroplasty in Proximal Femur Fractures: Insights and Challenges. HHA, MRSA, PCR, PFFs, PJI
96  2021 Prevalence and Outcomes of Multi-Drug Resistant Blood Stream Infections Among Nursing Home Residents Admitted to an Acute Care Hospital. BSIs
97  2021 Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country. A cross-sectional study. AKUH, CRE, ESBL, MDR, MDROs, MRSA, VRE
98  2021 Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients. aGVHD, BSI, C.diff, HSCT
99  2021 The effect of multidrug-resistant organisms on social participation and quality of life in children with life-limiting conditions. QoL
100  2021 The Impact of Timing of Stent Removal on the Incidence of UTI, Recurrence, Symptomatology, Resistance, and Hospitalization in Renal Transplant Recipients. ESR, LSR, UTIs